Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$245K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 8 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Mar 24 | ACAD | Acadia Pharmaceuticals INC | MEXER | 7,515 | — | — | +98.8% | Open the original filing on SEC.gov |
| Mar 6 | ACAD | Acadia Pharmaceuticals INC | AGRANT◆ | 26,382 | — | — | — | Open the original filing on SEC.gov |
| Mar 6 | ACAD | Acadia Pharmaceuticals INC | AGRANT◆ | 90,691 | — | — | — | Open the original filing on SEC.gov |
| Feb 9 | ACAD | Acadia Pharmaceuticals INC | SSELL◷? | 6,950 | $23.38 | $162.5K | -47.7% | Open the original filing on SEC.gov |
| Feb 6 | ACAD | Acadia Pharmaceuticals INC | MEXER◆ | 12,944 | — | — | — | Open the original filing on SEC.gov |
| Feb 6 | ACAD | Acadia Pharmaceuticals INC | MEXER | 12,944 | — | — | +801.5% | Open the original filing on SEC.gov |